What question did this study set out to answer?

Evaluate the role of phytochemicals in asthma management and identify barriers to their clinical integration.

June 19, 2026Phytochemicals in Food and MedicineOpen Access

Phytochemicals in Asthma Management: Mechanism, Translational Gap and Clinical Integration

View Full Paper

Ask AI

Bookmark

Evaluate the role of phytochemicals in asthma management and identify barriers to their clinical integration.
Systematic review following PRISMA guidelines across PubMed, Scopus, and Web of Science (2004–2026).
Inclusion of studies reporting asthma-related outcomes of phytochemicals in preclinical or clinical settings.
Evidence quality assessed using the GRADE framework.
Quercetin reduces airway inflammation by modulating PI3K/Akt/mTOR signaling and suppressing Th2 cytokines.
Glycyrrhizin enhances corticosteroid responsiveness and is in Phase III trials for severe asthma.
Barriers to clinical use include poor bioavailability and safety concerns such as hepatotoxicity.

No takes yet. Share an insight, caveat, or question.

Systematic review investigates phytochemicals for asthma management, highlighting advantages and gaps in clinical use.

Majumder et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark